Filing Details
- Accession Number:
- 0001144204-16-103868
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-05-20 12:08:42
- Reporting Period:
- 2016-05-19
- Filing Date:
- 2016-05-20
- Accepted Time:
- 2016-05-20 12:08:42
- Original Submission Date:
- 2016-05-20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1563665 | Biostage Inc. | BSTG | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1345855 | H Thomas Robinson | C/O Biostage, Inc. 84 October Hill Road, Suite 11 Holliston MA 01746 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-19 | 18,000 | $1.36 | 18,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This report is being filed to amend the footnote description contained in a Form 4 pertaining to the above transaction, filed on 5/20/2016. The description contained in that Form 4 filing incorrectly described the transaction as a sale instead of a purchase of shares.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.315 to $1.38, inclusive. The reporting person undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.